CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Viventia Biotech Inc.

For profit

Also known as: Novopharm Ltd | Viventia Bio

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Dec 1, 2005

Last known activity

Aug 1, 2015

Acquired by Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio on Sep 21, 2016

Timeline

1990s

  1. Jun 1, 1995

    Viventia Biotech Inc.— Founded

2010s

  1. Sep 21, 2016

    Sesen Bio— Acquired By

2020s

  1. Sep 21, 2022

    Sesen Bio— Now

Drugs by trial phase (2 distinct, 5 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Recent trials (9)

Details

Founded
Winnipeg, CA Jun 1, 1995
Last known activity
Aug 1, 2015